Release Date: 20/04/23 08:11 Summary: Change in substantial holding from RMS Price Sensitive: No Download Document 96.82KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%